PO3 0.00% 22.0¢ purifloh limited

PuriflOH targets hotel industry?

  1. 1,174 Posts.
    lightbulb Created with Sketch. 588
    Last month, - on April 30 - PuriflOH intrigued holders with cryptic references to expansion in Australia.

    The Company has “commenced detailed discussions for FRG based treatment systems to be integrated into Australian commercial sites”, PO3 said.

    “Engineering design and analysis is being undertaken at present.

    “PuriflOH has engaged the services of a Somnio engineer who has recently relocated to Melbourne and will assist with design work as well as research and development within Australia on specific opportunities identified by the
    Company.”

    Question: What kind of “commercial sites” is PO3 targeting?

    Clues may be found at the company’s website.

    PuriflOH has republished a New York Timesreport on air purifiers in the hotel industry.

    In January, the 556-room InterContinental San Francisco installed Molekule air purifiers in 30 of its rooms as part of a pilot project.


    According to Molekule’s chief executive, Dilip Goswami, the two-foot tall, cylindrical devices plug into a power outlet and eliminate mold, bacteria, chemicals, allergens and viruses through the company’s patented air purification technology.

    Harry Hobbs, an area director of engineering for InterContinental Hotels, said that indoor air quality is more important to the hotel following the wildfires that occurred last year in Paradise, Calif., about a three-hour drive away.


    “Even though the wildfires weren’t near the city, they affected the air quality, and many of our guests asked us for masks and filters because they had breathing difficulties.

    “Our staff was also uncomfortable,” he said.

    “After this initial trial, I want to offer cleaner air in more rooms and more hotels.”

    The wellness technology company Delos is behind the “Stay Well” designation of more than 1,000 hotel rooms found globally, including those in Wyndham, Marriott and MGM Grand hotels.


    One of their key features is a wall-mounted air-purification filter that aims to reduce allergens and microbes.

    When The Oberoi in New Delhi reopened last year following a renovation, air purifiers were installed throughout the hotel, including in all the rooms, to combat the worsening issue of Delhi’s polluted air.


    More than 40 of the new purifiers filter exterior air as it enters the building; the hotel also measures the quality of the interior air twice a day.

    While The New York Times report has nothing to say about air purifiers in Australian hotels, I would suggest that PuriflOH is targeting the local accommodation industry.

    PO3’s major shareholder is Dilato Holdings. The two companies share office premises at Ross Place, South Melbourne.

    Dilato Holdings controls Dilato Investments.

    On June 26, 2017, Melbourne’s CBD News published this report:

    A 22-storey luxury hotel may soon soar from an under-utilised, 10-storey office building at 422 Little Collins St.

    Dilato Investments has submitted a planning application to the City of Melbourne to build an additional 13 levels, including a mezzanine, on top of the existing structure.

    The current building will be retrofitted and the new roof will be turned into an outdoor-terraced podium with extensive views.

    Melbourne-based Metier 3 Architects designed the $40 million project, which aims for retention and revitalisation of the under-utilised building and surrounding laneways.

    The building will be home to a potential international hotel with 263 rooms on the 956 sqm site.

    Dilato has recently received a planning permit for the Little Collins St site.

    A sequel may be that PuriflOH supplies 250-300 air purifiers to the Dilato hotel project.

    The purifiers will presumably manufactured in Detroit by PO3’s Novi-based affiliate, Somnio Global.
    Last edited by Medify: 19/05/19
 
watchlist Created with Sketch. Add PO3 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.